However, there have been many studies on miR-139-5p in the progression and mechanism of hepatocellular carcinoma, while there have been relatively few studies on miR-582-3p in this area; therefore, miR-582-3p/SMAD2 was selected for follow-up studies in this project. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.